Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Cryo-Cell International, Inc. CCEL
$4.62
+$0.28 (5.96%)
На 18:03, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
42701282.00000000
-
week52high
8.12
-
week52low
2.69
-
Revenue
30336749
-
P/E TTM
15
-
Beta
0.27889200
-
EPS
0.27000000
-
Last Dividend
0.90000000
-
Next Earnings Date
10 июл 2023 г. в 10:59
Описание компании
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Maxim Group | Buy | 29 авг 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| TAYMANS JILL M | A | 20000 | 20000 | 13 янв 2023 г. |
| PORTNOY DAVID | A | 50000 | 50000 | 03 янв 2023 г. |
| Mikulinsky Oleg | A | 10000 | 10000 | 03 янв 2023 г. |
| Portnoy Mark L. | A | 25000 | 25000 | 03 янв 2023 г. |
| PORTNOY DAVID | A | 50000 | 50000 | 23 дек 2022 г. |
| Portnoy Mark L. | A | 25000 | 25000 | 23 дек 2022 г. |
| PORTNOY DAVID | A | 230621 | 2 | 18 ноя 2022 г. |
| PORTNOY DAVID | A | 230619 | 532 | 18 ноя 2022 г. |
| PORTNOY DAVID | A | 230087 | 516 | 17 ноя 2022 г. |
| PORTNOY DAVID | A | 229571 | 9491 | 15 ноя 2022 г. |
Новостная лента
Cryo-Cell International: A Stable Business Paired With An Upcoming Catalyst
Seeking Alpha
11 февр 2022 г. в 17:16
Cryo-Cell International has a stable business that generates consistent cash flow. The company is close to monetizing a partnership with Duke University to bring patented stem cell treatments to market.
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results
GlobeNewsWire
15 окт 2021 г. в 16:36
OLDSMAR, Fla., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2021.
Cryo-Cell International Announces Changes To Its Board of Directors
GlobeNewsWire
20 сент 2021 г. в 18:05
MIAMI, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (Nasdaq:CCEL), the leader in cord blood and cord tissue cryopreservation services, announces the appointment of Mr. Mark Portnoy and Mr. Daniel Mizrahi to the Company's Board of Directors, replacing Mr. George Gaines and Jonathan Wheeler, M.D., who have resigned in their capacity as Directors. Mr. Gaines has chosen to retire while Dr. Wheeler has resigned for health reasons.
Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market
GlobeNewsWire
30 авг 2021 г. в 09:00
Cryo-Cell International, Inc. (Symbol CCEL), The Leader In Cord Blood And Cord Tissue Cryopreservation Services, Today Announced That The Company's Common Stock Has Been Approved For Listing On The Nasdaq Capital Market (“Nasdaq”).
Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies
GlobeNewsWire
20 авг 2021 г. в 09:04
Cryo-Cell International (symbol: CCEL) Purchases Real Estate Location for its Institute for Cellular Therapies in the Raleigh-Durham area.